Resource Guide: FDA warning Tysabri Progressive Multifocal Leukoencephalopathy

A curated reading list of authoritative medical research, drug-safety databases, and focused analysis for researchers, patients, and advocates.

Featured analysis

FDA warning Tysabri Progressive Multifocal Leukoencephalopathy

Detailed background, context, and analysis on this topic, compiled for open research purposes.

U.S. Food and Drug Administration (FDA)

Reference: U.S. Food and Drug Administration (FDA)

Authoritative source for clinical, regulatory, and public-health background reading.

Mayo Clinic — Diseases & Conditions

Reference: Mayo Clinic — Diseases & Conditions

Authoritative source for clinical, regulatory, and public-health background reading.